Cochrane Abstracts
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Muscarinic Antagonist (LAMA) Plus Long‐acting Beta‐agonist (LABA) Versus LABA Plus Inhaled Corticosteroid (ICS) for Stable Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431206/all/Long���acting_muscarinic_antagonist__LAMA__plus_long���acting_beta���agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease. Accessed 30 November 2023.
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431206/all/Long���acting_muscarinic_antagonist__LAMA__plus_long���acting_beta���agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease. Accessed November 30, 2023.
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431206/all/Long���acting_muscarinic_antagonist__LAMA__plus_long���acting_beta���agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease
Long‐acting Muscarinic Antagonist (LAMA) Plus Long‐acting Beta‐agonist (LABA) Versus LABA Plus Inhaled Corticosteroid (ICS) for Stable Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431206/all/Long���acting_muscarinic_antagonist__LAMA__plus_long���acting_beta���agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
ID - 431206
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431206/all/Long���acting_muscarinic_antagonist__LAMA__plus_long���acting_beta���agonist__LABA__versus_LABA_plus_inhaled_corticosteroid__ICS__for_stable_chronic_obstructive_pulmonary_disease
DB - Evidence Central
DP - Unbound Medicine
ER -
